Gastañaduy PA, Goodson JL, Panagiotakopoulos L, Rota PA, Orenstein WA, Patel M. Measles in the 21st century: progress toward achieving and sustaining elimination. J Infect Dis. 2021;224:S420–8.

Article  PubMed  PubMed Central  Google Scholar 

Minta AA, Ferrari M, Antoni S, Portnoy A, Sbarra A, Lambert B, Hatcher C, Hsu CH, Ho LL, Steulet C, Gacic-Dobo M, Rota PA, Mulders MN, Bose AS, Caro WP, O’Connor P, Crowcroft NS. Progress toward measles elimination — worldwide, 2000–2022. MMWR Recomm Rep. 2023;72:1262–8.

Google Scholar 

World Health Organization (WHO). Global vaccine action plan. Vaccine. 2013;31:B5-31.

Article  Google Scholar 

World Health Organization. Measles vaccines: WHO position paper, April 2017 – Recommendations, Vaccine. Measles Vaccines. 2019;37:219–22.

Tariku MK, Worede DT, Belete AH, Bante SA, Misikir SW. Attack rate, case fatality rate and determinants of measles infection during a measles outbreak in Ethiopia: systematic review and meta-analysis. BMC Infect Dis. 2023;23:1–9.

Article  Google Scholar 

Franconeri L, Antona D, Cauchemez S, Lévy-Bruhl D, Paireau J. Two-dose measles vaccine effectiveness remains high over time: a French observational study, 2017–2019. Vaccine. 2023;41:5797–804.

Article  PubMed  Google Scholar 

CDC (2019). https://www.cdc.gov/globalhealth/measles/globalmeaslesoutbreaks.htm. Accessed Dec 2024.

World Health Organization (WHO). Manual for the laboratory-based surveillance of measles, rubella, and congenital rubella syndrome. Available at WHO Laboratory Surveillance Manual. WHO Libr. 2018;3–5.

Wang L, Haralambieva IH, Ovsyannikova IG, Grill DE, Warner ND, Poland GA, Kennedy RB. Associations of adaptive immune cell subsets with measles, mumps, and rubella−specific immune response outcomes. Heliyon. 2023;9: e22998.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yunusa A, Cabral C, Anderson E. The impact of the COVID-19 pandemic on the uptake of routine maternal and infant vaccines globally: a systematic review. PLOS Glob Public Heal. 2022;2:1–21.

Google Scholar 

Parums DV. A review of the resurgence of measles, a vaccine-preventable disease, as current concerns contrast with past hopes for measles elimination. Med Sci Monit. 2024;30:1–10.

Article  Google Scholar 

Chippaux J-P. Impact of COVID-19 on public health in sub-Saharan Africa. Bull Acad Natl Med. 2023;207:150–64.

PubMed  PubMed Central  Google Scholar 

Tanne JH. Measles cases and deaths are increasing worldwide, say WHO and CDC. BMJ. 2023;383: p2733.

Article  Google Scholar 

Masresha BG, Shibeshi ME, de Wee R, Shapumba N, Sayi T, Reef SE, Goodson JL. On the path to measles and rubella elimination following rubella-containing vaccine introduction, 2000–2023, Namibia. Vaccines. 2024;12:957.

Article  PubMed  PubMed Central  Google Scholar 

Nchasi G, Paul IK, Sospeter SB, Mallya MR, Ruaichi J, Malunga J. Measles outbreak in sub-Saharan Africa amidst COVID-19: a rising concern, efforts, challenges, and future recommendations. Ann Med Surg. 2022;81: 104264.

Article  Google Scholar 

Masresha BG, Wiysonge CS, Katsande R, O’Connor PM, Lebo E, Perry RT. Tracking measles and rubella elimination progress—World Health Organization African Region, 2022–2023. Vaccines. 2024;12:2022–3.

Article  Google Scholar 

World Health Organization (WHO). Measles and rubella strategic framework 2021–2030. World Health Organization. Available at WHO Measles and Rubella Strategic Framework. 2024.

Michael F, Mirambo MM, Misinzo G, Minzi O, Beyanga M, Mujuni D, et al. Trends of measles in Tanzania: a 5-year review of case-based surveillance data, 2018–2022. Int J Infect Dis. 2024;139:176–82.

Article  PubMed  PubMed Central  Google Scholar 

Sangeda RZ, James D, Mariki H, Mbwambo ME, Mwenesi ME, Nyaki H, Tinuga F, Manyanga DP. Childhood vaccination trends during 2019 to 2022 in Tanzania and the impact of the COVID-19 pandemic. Hum Vaccines Immunother. 2024;20(1):2356342.

Tanzania National Bureau of Statistics (NBS). 2022 Population and housing census: temeke district report. National Bureau of Statistics, Tanzania. Available at NBS Census. 2022.

Drago F, Ciccarese G, Merlo G, Trave I, Javor S, Rebora A, Parodi A. Oral and cutaneous manifestations of viral and bacterial infections: not only COVID-19 disease. Clin Dermatol. 2021;39:384–404.

Article  PubMed  PubMed Central  Google Scholar 

Boteler WL, Luipersbeck PM, Fuccillo DA, O’Beirne AJ. Enzyme-linked immunosorbent assay for detection of measles antibody. J Clin Microbiol. 1983;17(5):814–8.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Rachlin A, Hampton LM, Rota PA, Mulders MN, Papania M, Goodson JL, et al. Use of measles and rubella rapid diagnostic tests to improve case detection and targeting of vaccinations. Vaccines. 2024;12:12.

Article  Google Scholar 

Nguyen THT, Nguyen TV, Luong QC, Ho TV, Faes C, Hens N. Understanding the transmission dynamics of a large-scale measles outbreak in Southern Vietnam. Int J Infect Dis. 2022;122:1009–17.

Article  PubMed  Google Scholar 

Adekola HA, Abdullahi IN, Emeribe AU, Faruku N, Uzairue L, Adeyemi Billyrose OM, et al. Sero-survey of measles virus antibodies among symptomatic children attending Abuja Teaching Hospital, Nigeria. GMS Hyg Infect Control. 2021;16:Doc04.

PubMed  PubMed Central  Google Scholar 

Plans-Rubió P. Are the objectives proposed by the WHO for routine measles vaccination coverage and population measles immunity sufficient to achieve measles elimination from Europe? Vaccines. 2020;8:8.

Article  Google Scholar 

Younes N, Al-SAdeq DW, Al-Jighefee H, Younes S, Al-Jamal O, Daas HI, et al. Challenges in laboratory diagnosis of the novel. Viruses. 2020;12:582.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Mkopi A, Mtenga S, Festo C, Mhalu G, Shabani J, Tillya R, Masemo A, Kheir K, Nassor M, Mwengee W, Lyimo D, Masanja H. Factors affecting non-coverage of measles-rubella vaccination among children aged 9–59 months in Tanzania. Vaccine. 2021;39:6041–9.

Article  PubMed  Google Scholar 

Carson KJ, Tucker HR, Howard K, Hales M, Bryant PW, St George K, Kulas KE, Lee WT. Evaluation of measles IgM antibody detection assays during the 2018–2019 outbreak in New York State. Diagn Microbiol Infect Dis. 2022;104: 115741.

Article  PubMed  CAS  Google Scholar 

Misin A, Antonello RM, Di Bella S, Campisciano G, Zanotta N, Giacobbe DR, et al. Measles: an overview of a re-emerging disease in children and immunocompromised patients. Microorganisms. 2020;8:1–16.

Article  Google Scholar 

Wolfson LJ, Grais RF, Luquero FJ, Birmingham ME, Strebel PM. Estimates of measles case fatality ratios: a comprehensive review of community-based studies†. Int J Epidemiol. 2009;38:192–205.

Article  PubMed  Google Scholar 

Paules CI, Marston HD, Fauci AS. Measles in, — going backward. N Engl J Med. 2019;2019:2185–7.

Article  Google Scholar 

Griffin DE. Measles virus persistence and its consequences. Curr Opin Virol. 2020;41:46–51.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Schenk J, Abrams S, Litzroth A, Cornelissen L, Grammens T, Theeten H, et al. Identifying immunity gaps for measles using Belgian serial serology data. Vaccine. 2022;40:3676–83.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yang L, Grenfell BT, Mina MJ. Waning immunity and re-emergence of measles and mumps in the vaccine era. Curr Opin Virol. 2020;40:48–54.

Article  PubMed  Google Scholar 

Alemu TG, Tamir TT, Workneh BS, Mekonen EG, Ali MS, Zegeye AF, et al. Coverage and determinants of second-dose measles vaccination among under-five children in East Africa countries: a systematic review and meta-analysis. Front Public Heal. 2024;12:12.

Google Scholar 

Sowers SB, Anthony K, Mercader S, Colley H, Crooke SN, Rota PA, et al. Performance characteristics of six immunoglobulin M enzyme-linked immunosorbent assays used for laboratory confirmation of measles. J Clin Microbiol. 2022;60:1–8.

Article  CAS  Google Scholar 

Bolotin S, Hughes SL, Gul N, Khan S, Rota PA, Severini A, et al. What is the evidence to support a correlate of protection for measles? A systematic review. J Infect Dis. 2020;221:1576–83.

Article  PubMed  CAS  Google Scholar 

Ibrahim HA, Wariyo A, Asefa EM, Cheru A, Abebe Lonsako A, Dirirsa G. Measles second dose vaccine uptake and associated factors among under-five children in Jigjiga City, Somali Region, Eastern Ethiopia: a community-based cross-sectional study. Front Public Heal. 2024;12:1–10.

Google Scholar 

Majekodunmi OB, Oladele EAGB. Factors affecting poor measles vaccination coverage in sub-Saharan Africa with a special focus on Nigeria: a narrative review. Trans R Soc Trop Med Hyg. 2022;116:686–93.

Article  PubMed  Google Scholar 

Lyamuya EF, Matee MI, Aaby P, Scheutz F. Serum levels of measles IgG antibody activity in children under 5 years in Dar es Salaam, Tanzania. Ann Trop Paediatr. 1999;19:175–83.

Article  PubMed